These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 1677414)

  • 1. Influenza virus RNA in the lung and lymphoid tissue of immunologically intact and CD4-depleted mice.
    Eichelberger MC; Wang ML; Allan W; Webster RG; Doherty PC
    J Gen Virol; 1991 Jul; 72 ( Pt 7)():1695-8. PubMed ID: 1677414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of long lasting persistence of influenza virus antigens at the portal of infection and in the spleen of mice.
    Dubrovina TYa ; Ivanova IA; Shidlovskaya NK; Polyak RYa
    Acta Virol; 1992 Oct; 36(5):450-8. PubMed ID: 1364021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of the influenza virus-specific CD4+ T cell memory in the absence of B cells and Ig.
    Topham DJ; Tripp RA; Hamilton-Easton AM; Sarawar SR; Doherty PC
    J Immunol; 1996 Oct; 157(7):2947-52. PubMed ID: 8816401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence analysis of the haemagglutinin (HA) of influenza A (H1N1) viruses present in clinical material and comparison with the HA of laboratory-derived virus.
    Robertson JS; Nicolson C; Bootman JS; Major D; Robertson EW; Wood JM
    J Gen Virol; 1991 Nov; 72 ( Pt 11)():2671-7. PubMed ID: 1940864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced viral clearance in interleukin-18 gene-deficient mice after pulmonary infection with influenza A virus.
    Van Der Sluijs KF; Van Elden LJ; Arens R; Nijhuis M; Schuurman R; Florquin S; Kwakkel J; Akira S; Jansen HM; Lutter R; Van Der Polls T
    Immunology; 2005 Jan; 114(1):112-20. PubMed ID: 15606801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells.
    Allan W; Tabi Z; Cleary A; Doherty PC
    J Immunol; 1990 May; 144(10):3980-6. PubMed ID: 1692070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the haemagglutinin or nucleoprotein of influenza virus.
    Endo A; Itamura S; Iinuma H; Funahashi S; Shida H; Koide F; Nerome K; Oya A
    J Gen Virol; 1991 Mar; 72 ( Pt 3)():699-703. PubMed ID: 2005435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of viral burden in tissues from adults and children with symptomatic human immunodeficiency virus type 1 infection assessed by polymerase chain reaction.
    Sei S; Kleiner DE; Kopp JB; Chandra R; Klotman PE; Yarchoan R; Pizzo PA; Mitsuya H
    J Infect Dis; 1994 Aug; 170(2):325-33. PubMed ID: 8035018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Properties of influenza virus isolated from the bodies of mice at different stages of experimental influenza].
    Frolov AF; Shcherbinskaia AM; Sklianskaia EI
    Vopr Virusol; 1981; (5):544-7. PubMed ID: 7336682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung.
    Duhaut SD; Dimmock NJ
    Virology; 1998 Sep; 248(2):241-53. PubMed ID: 9721233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhalatory infection of mice with influenza A0/PR8 virus. II. Detection of the virus in the blood and extrapulmonary organs.
    Franková V; Rychterová V
    Acta Virol; 1975 Jan; 19(1):35-40. PubMed ID: 235195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection.
    Tamura S; Iwasaki T; Thompson AH; Asanuma H; Chen Z; Suzuki Y; Aizawa C; Kurata T
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():291-9. PubMed ID: 9472613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CC chemokine receptor 7 expression by effector/memory CD4+ T cells depends on antigen specificity and tissue localization during influenza A virus infection.
    Debes GF; Bonhagen K; Wolff T; Kretschmer U; Krautwald S; Kamradt T; Hamann A
    J Virol; 2004 Jul; 78(14):7528-35. PubMed ID: 15220427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of the influenza A/WSN/33 virus RNA at midbrain levels of immunodefective mice.
    Aronsson F; Karlsson H; Ljunggren HG; Kristensson K
    J Neurovirol; 2001 Apr; 7(2):117-24. PubMed ID: 11517384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells.
    Hou S; Doherty PC; Zijlstra M; Jaenisch R; Katz JM
    J Immunol; 1992 Aug; 149(4):1319-25. PubMed ID: 1354233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunodominance correlates with T-cell receptor (alpha beta) gene usage in the class II-restricted response to influenza haemagglutinin.
    Smith CA; Graham CM; Thomas DB
    Immunology; 1994 Jul; 82(3):343-50. PubMed ID: 7959866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lethal coinfection of influenza virus and Streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph Node.
    Wu Y; Tu W; Lam KT; Chow KH; Ho PL; Guan Y; Peiris JS; Lau YL
    J Virol; 2015 Feb; 89(4):2013-23. PubMed ID: 25428873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza A virus haemagglutinin polymorphism: pleiotropic antigenic variants of A/Shanghai/11/87 (H3N2) virus selected as high yield reassortants.
    Kilbourne ED; Johansson BE; Moran T; Wu S; Pokorny BA; Xu X; Cox N
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1311-6. PubMed ID: 8336120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prominent usage of V beta 8.3 T cells in the H-2Db-restricted response to an influenza A virus nucleoprotein epitope.
    Deckhut AM; Allan W; McMickle A; Eichelberger M; Blackman MA; Doherty PC; Woodland DL
    J Immunol; 1993 Sep; 151(5):2658-66. PubMed ID: 7689611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.